Latest drug discovery Stories
DALLAS, April 17, 2015 /PRNewswire/ -- LifeScienceIndustryResearch.com adds Dyskinesia - Pipeline Review, H1 2015 and Dyskinesia Global Clinical Trials Review, H1, 2015
KYOTO and OSAKA, Japan, April 16, 2015 /PRNewswire/ -- Center for iPS Cell Research Application (CiRA) of Kyoto University and Takeda Pharmaceutical Company Limited (Takeda) announced today
LONDON, April 16, 2015 /PRNewswire/ -- SummaryGBI Research, the leading business intelligence provider, has released its latest research,'Pancreatic Adenocarcinoma Therapeutics
THE WOODLANDS, Texas, April 15, 2015 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical
CAMBRIDGE, England and BUDAPEST, Hungary, April 15, 2015 /PRNewswire/ -- - Interface between StarDrop and Plexus facilitates seamless access to both software platforms
GIA announces the release of a comprehensive global report on Microplate Instrumentation & Supplies.
RnRMarketResearch.com adds “Endothelial Dysfunction Global Clinical Trials Review, H1, 2015” to its store.
Novel Product Focused On Treatment of Comorbidities of Sickle Cell Disease SOUTH PLAINFIELD, N.J., April 8, 2015 /PRNewswire/ -- Prolong Pharmaceuticals, LLC, a biopharmaceutical company
CAMBRIDGE, Mass., April 8, 2015 /PRNewswire/ -- Blueprint Medicines today announced it will present new preclinical data on its drug candidate BLU-285 in gastrointestinal stromal tumors (GIST), as
- A serpent whose bite was fabled to produce intense thirst.